Roseline Vibert

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine

Célia Dupain, Tom Gutman, Elodie Girard et al. · BMC Biology · 2024 · 17 citations · Full text

Medicine, Bioinformatics, Oncology +17

<i>AXIN2</i> germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer

Julie Leclerc, Marie Beaumont, Roseline Vibert et al. · Genes Chromosomes and Cancer · 2022 · 13 citations · Full text

Medicine, Genetics, Oncology +17

Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic

Patrick R. Benusiglio, Clément Korenbaum, Roseline Vibert et al. · European Journal of Medical Genetics · 2020 · 12 citations · Full text

Medicine, Genetics, Oncology +14

Cancer risk and tumour spectrum in 172 patients with a germline <i>SUFU</i> pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group

Léa Guerrini‐Rousseau, Julien Masliah‐Planchon, Sebastian M. Waszak et al. · Journal of Medical Genetics · 2022 · 12 citations · Full text

Life Sciences, Genetics, Oncology +17

Minors at risk of von Hippel-Lindau disease: 10 years’ experience of predictive genetic testing and follow-up adherence

Roseline Vibert, Khadija Lahlou‐Laforêt, Maryam Samadi et al. · European Journal of Human Genetics · 2022 · 11 citations · Full text

Life Sciences, Genetics, Health Sciences +15